Association between serum uric acid level and peripheral arterial disease

Atherosclerosis

Volumn 196, Issue 2, 2008, Pages 749-755

  Shankar, Anoop ^a   Klein, Barbara E K ^b   Nieto, F Javier ^b   Klein, Ronald ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

ABI; Ankle brachial index; NHANES; PAD; Peripheral arterial disease; Serum uric acid

Indexed keywords

CHOLESTEROL; CREATININE; URIC ACID;

ADULT; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SMOKING; URIC ACID BLOOD LEVEL;

ADULT; AGED; ANKLE; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; URIC ACID;

EID: 38549159476     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.12.029     Document Type: Article

References (71)

1. Hertzer N.R., Beven E.G., Young J.R., et al. Coronary artery disease in peripheral vascular patients A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199 (1984) 223-233
2. Klop R.B., Eikelboom B.C., and Taks A.C. Screening of the internal carotid arteries in patients with peripheral vascular disease by colour-flow duplex scanning. Eur J Vasc Surg 5 (1991) 41-45
3. Missouris C.G., Buckenham T., Cappuccio F.P., and MacGregor G.A. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med 96 (1994) 10-14
4. Newman A.B., Siscovick D.S., Manolio T.A., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88 (1993) 837-845
5. McKenna M., Wolfson S., and Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87 (1991) 119-128
6. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
7. Vogt M.T., Cauley J.A., Newman A.B., Kuller L.H., and Hulley S.B. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA 270 (1993) 465-469
8. Newman A.B., Shemanski L., Manolio T.A., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19 (1999) 538-545
9. Zheng Z.J., Sharrett A.R., Chambless L.E., et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 131 (1997) 115-125
10. Abbott R.D., Rodriguez B.L., Petrovitch H., et al. Ankle-brachial blood pressure in elderly men and the risk of stroke: the Honolulu Heart Program. J Clin Epidemiol 54 (2001) 973-978
11. Tsai A.W., Folsom A.R., Rosamond W.D., and Jones D.W. Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke 32 (2001) 1721-1724
12. Leng G.C., Fowkes F.G., Lee A.J., et al. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 313 (1996) 1440-1444
13. Murabito J.M., Evans J.C., Larson M.G., et al. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med 163 (2003) 1939-1942
14. Resnick H.E., Lindsay R.S., McDermott M.M., et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109 (2004) 733-739
15. Freedman D.S., Williamson D.F., Gunter E.W., and Byers T. Relation of serum uric acid to mortality and ischemic heart disease The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 141 (1995) 637-644
16. Alderman M.H., Cohen H., Madhavan S., and Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 34 (1999) 144-150
17. Fang J., and Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study 1971-1992. National Health and Nutrition Examination Survey. JAMA 283 (2000) 2404-2410
18. Levine W., Dyer A.R., Shekelle R.B., Schoenberger J.A., and Stamler J. Serum uric acid and 11, 5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 42 (1989) 257-267
19. Gerber Y., Tanne D., Medalie J.H., and Goldbourt U. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil 13 (2006) 193-198
20. Chien K.L., Hsu H.C., Sung F.C., et al. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 183 (2005) 147-155
21. Moriarity J.T., Folsom A.R., Iribarren C., Nieto F.J., and Rosamond W.D. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 10 (2000) 136-143
22. Hozawa A., Folsom A.R., Ibrahim H., et al. Serum uric acid and risk of ischemic stroke: The ARIC Study. Atherosclerosis 187 (2006) 401-407
23. Niskanen L.K., Laaksonen D.E., Nyyssonen K., et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164 (2004) 1546-1551
24. Klein R., Klein B.E., Cornoni J.C., et al. Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 132 (1973) 401-410
25. Culleton B.F., Larson M.G., Kannel W.B., and Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131 (1999) 7-13
26. Wheeler J.G., Juzwishin K.D., Eiriksdottir G., Gudnason V., and Danesh J. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med 2 (2005) e76
27. Kahn H.A., Medalie J.H., Neufeld H.N., Riss E., and Goldbourt U. The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J 84 (1972) 171-182
28. Jossa F., Farinaro E., Panico S., et al. Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 8 (1994) 677-681
29. Sundstrom J., Sullivan L., D'Agostino R.B., et al. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 45 (2005) 28-33
30. Klein B.E., Klein R., and Lee K.E. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diab Care 25 (2002) 1790-1794
31. Lee J., Sparrow D., Vokonas P.S., Landsberg L., and Weiss S.T. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome The Normative Aging Study. Am J Epidemiol 142 (1995) 288-294
32. Facchini F., Chen Y.D., Hollenbeck C.B., and Reaven G.M. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266 (1991) 3008-3011
33. Schmidt M.I., Duncan B.B., Watson R.L., et al. A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diab Care 19 (1996) 414-418
34. Patel D.A., Srinivasan S.R., Xu J.H., et al. Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study. Metabolism 55 (2006) 699-705
35. Ruggiero C., Cherubini A., Ble A., et al. Uric acid and inflammatory markers. Eur Heart J 27 (2006) 1174-1181
36. Glantzounis G.K., Tsimoyiannis E.C., Kappas A.M., and Galaris D.A. Uric acid and oxidative stress. Curr Pharm Des 11 (2005) 4145-4151
37. Tan S., Radi R., Gaudier F., et al. Physiologic levels of uric acid inhibit xanthine oxidase in human plasma. Pediatr Res 34 (1993) 303-307
38. Kato M., Hisatome I., Tomikura Y., et al. Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol 96 (2005) 1576-1578
39. Erdogan D., Gullu H., Caliskan M., et al. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 59 (2005) 1276-1282
40. Iribarren C., Folsom A.R., Eckfeldt J.H., McGovern P.G., and Nieto F.J. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study Atherosclerosis Risk in Communities. Ann Epidemiol 6 (1996) 331-340
41. Kawamoto R., Tomita H., Oka Y., et al. Association between uric acid and carotid atherosclerosis in elderly persons. Intern Med 44 (2005) 787-793
42. Lowe G.D., Fowkes F.G., Dawes J., et al. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 87 (1993) 1915-1920
43. Vigna G.B., Bolzan M., Romagnoni F., et al. Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis. Circulation 85 (1992) 2205-2211
44. Tseng C.H. Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes. Diab Med 21 (2004) 724-729
45. Langlois M., De B.D., Duprez D., et al. Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis 168 (2003) 163-168
46. National Center for Health Statistics. NHANES 1999-2002 addendum to the NHANES III analytic guidelines [article online]; 2006. Available online from: www.cdc.gov/nchs/data/nhanes/guidelines1.pdf [accessed August 24 2006].
47. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 110 (2004) 738-743
48. American Diabetes Association. Peripheral arterial disease in people with diabetes (Consensus Statement). Diab Care 26 (2003) 3333-3341
49. National Center for Health Statistics. Lab methods NHANES 1999-2002; 2006. Available at: www.cdc.gov/nchs/data/nhanes/nhanes_01_02/l40_b_met_uric_acid.pdf [accessed August 24, 2006].
50. Coresh J., Byrd-Holt D., Astor B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults 1999-2000. J Am Soc Nephrol 16 (2005) 180-188
51. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
52. Kawamoto R., Tomita H., Oka Y., and Ohtsuka N. Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 45 (2006) 605-614
53. Tuttle K.R., Short R.A., and Johnson R.J. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 87 (2001) 1411-1414
54. Reaven G.M. The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis 30 (1997) 928-931
55. Quinones G.A., Natali A., Baldi S., et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 268 (1995) E1-E5
56. Muscelli E., Natali A., Bianchi S., et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 9 (1996) 746-752
57. Ishizaka N., Ishizaka Y., Toda E.I., et al. Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis (2006)
58. Tanemoto M., Saitoh H., Satoh F., et al. Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis. Hypertens Res 28 (2005) 237-242
59. Rao G.N., Corson M.A., and Berk B.C. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 266 (1991) 8604-8608
60. Kang D.H., Han L., Ouyang X., et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 25 (2005) 425-433
61. Farquharson C.A., Butler R., Hill A., Belch J.J., and Struthers A.D. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106 (2002) 221-226
62. Khosla U.M., Zharikov S., Finch J.L., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 67 (2005) 1739-1742
63. Jaramillo M., Naccache P.H., and Olivier M. Monosodium urate crystals synergize with IFN-gamma to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1/2 and NF-kappa B. J Immunol 172 (2004) 5734-5742
64. Yoo T.W., Sung K.C., Shin H.S., et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69 (2005) 928-933
65. Matsubara M., Chiba H., Maruoka S., and Katayose S. Elevated serum leptin concentrations in women with hyperuricemia. J Atheroscler Thromb 9 (2002) 28-34
66. Sanchez-Lozada L.G., Nakagawa T., Kang D.H., et al. Hormonal and cytokine effects of uric acid. Curr Opin Nephrol Hypertens 15 (2006) 30-33
67. Kanellis J., and Kang D.H. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 25 (2005) 39-42
68. Ames B.N., Cathcart R., Schwiers E., and Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78 (1981) 6858-6862
69. Rosell M., Regnstrom J., Kallner A., and Hellenius M.L. Serum urate determines antioxidant capacity in middle-aged men-a controlled, randomized diet and exercise intervention study. J Intern Med 246 (1999) 219-226
70. Nieto F.J., Iribarren C., Gross M.D., Comstock G.W., and Cutler R.G. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis 148 (2000) 131-139
71. Psaty B.M., Koepsell T.D., Lin D., et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 47 (1999) 749-754